← Back
Bambusa Therapeutics
BBTX · listed on Nasdaq · worth $796.19 million
$16.00
+6.74% on Nov 2
Two insiders bought $12 million of Bambusa Therapeutics stock in the last two weeks. The biggest buyer was Salvia Investment GmbH.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
3.6M shares
7% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, two insiders bought Bambusa Therapeutics stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Salvia Investment GmbH
Bought $6M on Nov 2 — 375,000 shares at $16.00, 4.0% of what they now own.
No earlier purchases to measure
10% owner
Helmut Wolfgang Jeggle
Bought $6M on Nov 2 — 375,000 shares at $16.00, held through a trust or family, 4.0% of what they now own.
No earlier purchases to measure
All reports
Every insider trade and SEC report we hold for Bambusa Therapeutics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue